Patent: 9,976,171
✉ Email this page to a colleague
Summary for Patent: 9,976,171
Title: | Method for dissolution testing of solid compositions containing digestive enzymes |
Abstract: | The invention is directed to a process for measuring the amount of digestive enzymes released from a solid composition in a dissolution medium by fluorescence spectroscopy. The invention is also directed to a combined method for measuring both the dissolution and gastroresistance of a solid compositions comprising pancrelipase. |
Inventor(s): | Latino; Massimo (Cinisello Balsamo, IT), Ghidorsi; Luigi (Milan, IT), Ortenzi; Giovanni (Monza, IT) |
Assignee: | ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (IE) |
Application Number: | 14/237,180 |
Patent Claims: | see list of patent claims |
Details for Patent 9,976,171
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | COTAZYM | pancrelipase | Capsule, Delayed Release | 020580 | 12/09/1996 | ⤷ Try a Trial | 2040-03-30 |
Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 04/30/2009 | ⤷ Try a Trial | 2040-03-30 |
Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 06/10/2011 | ⤷ Try a Trial | 2040-03-30 |
Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 03/14/2013 | ⤷ Try a Trial | 2040-03-30 |
Digestive Care, Inc. | PERTZYE | pancrelipase | Capsule, Delayed Release | 022175 | 05/17/2012 | ⤷ Try a Trial | 2040-03-30 |
Digestive Care, Inc. | PERTZYE | pancrelipase | Capsule, Delayed Release | 022175 | 10/06/2016 | ⤷ Try a Trial | 2040-03-30 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |